{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:16:02Z","timestamp":1791184562063,"version":"4.1.0"},"reference-count":35,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[1998,10,1]],"date-time":"1998-10-01T00:00:00Z","timestamp":907200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[1998,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            From 1992 to 1994 a screening program for detection of specific\n            <jats:italic>Toxoplasma gondii<\/jats:italic>\n            antibodies involving 35,940 pregnant women was conducted in Norway. For women with serological evidence of primary\n            <jats:italic>T. gondii<\/jats:italic>\n            infection, amniocentesis and antiparasitic treatment were offered. The amniotic fluid was examined for\n            <jats:italic>T. gondii<\/jats:italic>\n            by PCR and mouse inoculation to detect fetal infection. Infants of infected mothers had clinical and serological follow-up for at least 1 year to detect congenital infection. Of the women 10.9% were infected before the onset of pregnancy. Forty-seven women (0.17% among previously noninfected women) showed evidence of primary infection during pregnancy. The highest incidence was detected (i) among foreign women (0.60%), (ii) in the capital city of Oslo (0.46%), and (iii) in the first trimester (0.29%). Congenital infection was detected in 11 infants, giving a transmission rate of 23% overall, 13% in the first trimester, 29% in the second, and 50% in the third. During the 1-year follow-up period only one infant, born to an untreated mother, was found to be clinically affected (unilateral chorioretinitis and loss of vision). At the beginning of pregnancy 0.6% of the previously uninfected women were falsely identified as positive by the Platelia Toxo-IgM test, the percentage increasing to 1.3% at the end of pregnancy. Of the women infected prior to pregnancy 6.8% had persisting specific immunoglobulin M (IgM). A positive specific-IgM result had a low predictive value for identifying primary\n            <jats:italic>T. gondii<\/jats:italic>\n            infection.\n          <\/jats:p>","DOI":"10.1128\/jcm.36.10.2900-2906.1998","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T17:23:35Z","timestamp":1577813015000},"page":"2900-2906","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":122,"title":["Incidence of\n            <i>Toxoplasma gondii<\/i>\n            Infection in 35,940 Pregnant Women in Norway and Pregnancy Outcome for Infected Women"],"prefix":"10.1128","volume":"36","author":[{"given":"P\u00e5l A.","family":"Jenum","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Bacteriology1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babill","family":"Stray-Pedersen","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Department of Gynecology and Obstetrics, National Hospital,2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjetil K.","family":"Melby","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Department of Microbiology, Ullev\u00e5l University Hospital,3 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Kapperud","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Bacteriology1 and"},{"name":"<!--label omitted: 4-->Section of Food Hygiene, Norwegian College of Veterinary Medicine,4 Oslo, Norway, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Whitelaw","sequence":"additional","affiliation":[{"name":"<!--label omitted: 5-->Institute of Child Health, University of Bristol, Bristol, England5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Eskild","sequence":"additional","affiliation":[{"name":"<!--label omitted: 6-->Department of Social Medicine,6 National Institute of Public Health,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Eng","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Bacteriology1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","first-page":"160","article-title":"Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical cases","volume":"50","author":"Alford C. A.","year":"1974","unstructured":"Alford C. A. Stagno S. Reynolds D. W. Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical cases.Bull. N. Y. Acad. Med.501974160181","journal-title":"Bull. N. Y. Acad. Med."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1068150"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","unstructured":"Couvreur J. G. Desmonts and P. Thulliez. 1988. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection. J. Antimicrob. Chemother. 22 (Suppl. B):193\u2013200.","DOI":"10.1093\/jac\/22.Supplement_B.193"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198802043180502"},{"key":"e_1_3_1_6_2","unstructured":"Desmonts\nG.\nCouvreur\nJ.\nCongenital toxoplasmosis. A prospective study of the offspring of 542 women who acquired toxoplasmosis during pregnancy\nPerinatal medicine Sixth European Congress.\nThalhammer\nO.\nBaumgarten\nK.\nPollak\nA.\n1979\n51\n60\nGeorg Thieme\nStuttgart Germany"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92096-3"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.14.5.486-491.1981"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.11.6.562-568.1980"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/096914139600300406"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)93095-Q"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-994537"},{"key":"e_1_3_1_13_2","unstructured":"Griffiths\nR.\nMental development scales.\n1984\nThe Test Agency\nHigh Wycombe England"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01701532"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409153311102"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(89)80660-2"},{"key":"e_1_3_1_17_2","unstructured":"Ho-Yen\nD. O.\nClinical features\nHuman toxoplasmosis.\nHo-Yen\nD. O.\nJoss\nA. W. L.\n1992\n56\n78\nOxford Medical Publications\nOxford United Kingdom"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1998.tb00211.x"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268897008480"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.8.1972-1977.1997"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008942"},{"key":"e_1_3_1_22_2","first-page":"13","article-title":"The frequency of positive Toxoplasma dye test in children and adolescents with physical and mental handicaps","volume":"1","author":"Langset M.","year":"1978","unstructured":"Langset M. Aandahl E. Omland T. Midtvedt T. The frequency of positive Toxoplasma dye test in children and adolescents with physical and mental handicaps.NIPH Ann.119781319","journal-title":"NIPH Ann."},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1970.tb06573.x"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549209048407"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.3.691"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01701522"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549309008574"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.1.174-178.1997"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.1.38"},{"key":"e_1_3_1_30_2","first-page":"258","article-title":"Evaluation of seven commercially available enzyme immunoassays for immunoglobulin G and M antibody detection of Toxoplasma gondii","volume":"3","author":"Naessens A.","year":"1993","unstructured":"Naessens A. Heuninckx W. Foulon W. Lauwers S. Evaluation of seven commercially available enzyme immunoassays for immunoglobulin G and M antibody detection of Toxoplasma gondii.Immunol. Infect. Dis.31993258262","journal-title":"Immunol. Infect. Dis."},{"key":"e_1_3_1_31_2","unstructured":"Remington\nJ. S.\nMcLeod\nR.\nDesmonts\nG.\nToxoplasmosis\nInfectious diseases of the fetus and newborn infant\n4th ed.\nRemington\nJ. S.\nKlein\nJ. O.\n1995\n140\n267\nThe W. B. Saunders Company\nPhiladelphia Pa"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.108.2815.660"},{"key":"e_1_3_1_33_2","unstructured":"Statistics Norway\nStatistical yearbook 1995 114th issue.\n1995\nStatistics Norway\nOslo Norway"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(80)90870-4"},{"key":"e_1_3_1_35_2","first-page":"107","article-title":"Toxoplasmosis in pregnancy","volume":"7","author":"Stray-Pedersen B.","year":"1993","unstructured":"Stray-Pedersen B. Toxoplasmosis in pregnancy.Clin. Obstet. Gynaecol.71993107137","journal-title":"Clin. Obstet. Gynaecol."},{"key":"e_1_3_1_36_2","first-page":"80","article-title":"Current status of toxoplasmosis in pregnancy in Norway","volume":"84","author":"Stray-Pedersen B.","year":"1992","unstructured":"Stray-Pedersen B. Jenum P. Current status of toxoplasmosis in pregnancy in Norway.Scand. J. Infect. Dis. Suppl.8419928083","journal-title":"Scand. J. Infect. Dis. Suppl."}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.36.10.2900-2906.1998","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.36.10.2900-2906.1998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T23:31:14Z","timestamp":1646436674000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.36.10.2900-2906.1998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["10.1128\/JCM.36.10.2900-2906.1998"],"URL":"https:\/\/doi.org\/10.1128\/jcm.36.10.2900-2906.1998","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,10]]},"assertion":[{"value":"1997-12-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-06-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-10-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}